Daiichi Sankyo Wins $47M in ADC Patent Arbitration With Seagen, Pfizer Dispute Looms

Daiichi Sankyo announced on Friday that it has won its patent arbitration dispute with Seagen, which will pay the Japanese multinational $47 million in attorneys’ fees and costs, plus interest.